论文信息 - The use of memantine in dementia with Lewy bodies.

The use of memantine in dementia with Lewy bodies.

OBJECTIVE To determine the effect of memantine in the treatment of Dementia with Lewy Bodies (DLB). BACKGROUND While memantine has been used to successfully treat moderate-to-severe Alzheimer's disease (AD) and some non AD dementias, no reports are available regarding the effect of the drug on DLB. METHODS We reviewed the charts of 11 subjects with DLB by McKeith Criteria that were prospectively evaluated and treated with memantine (with or without cholinesterase inhibitors (ChEIs)) for varying lengths of time. RESULTS 9 of 11 DLB subjects on memantine were also on ChEIs. Seven of eleven were stable or improved with memantine while the remaining four worsened or responded adversely when exposed to the drug. No adverse effects on motor function were observed. CONCLUSIONS Memantine can be used safely in patients with DLB, but its symptomatic effects may be variable.

[1] L. Thal,et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease , 1998, Neurology.

[2] E. Perry,et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.

[3] Rachelle Doody,et al. Memantine in moderate-to-severe Alzheimer's disease. , 2003, The New England journal of medicine.

[4] Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300) , 2002, Stroke.

[5] B. Winblad,et al. Memantine in severe dementia: results of the 9M‐best study (benefit and efficacy in severly demented patients during treatment with memantine) , 1999, International journal of geriatric psychiatry.

[6] L A Hansen,et al. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. , 1998, Archives of neurology.